# Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial

Study · id `cardio:ct-nct01810224` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01810224](<https://clinicaltrials.gov/study/NCT01810224>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01810224

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 206 participants.

## Technical summary

Registry record NCT01810224. Randomized; double masking; primary purpose treatment. Start 2013-03 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 206 participants (planned count; ClinicalTrials.gov record NCT01810224, source copy `cardio:ctgov-nct01810224-2013-03-13`, retrieved 2026-10-26)
- Start date: 2013-03 (registry gives no type) (ClinicalTrials.gov record NCT01810224, source copy `cardio:ctgov-nct01810224-2013-03-13`, retrieved 2026-10-26)
- Primary completion: 2015-12 (anticipated) (ClinicalTrials.gov record NCT01810224, source copy `cardio:ctgov-nct01810224-2013-03-13`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: Belgium; Czechia; Hungary (ClinicalTrials.gov record NCT01810224, source copy `cardio:ctgov-nct01810224-2013-03-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01810224-2013-03-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial
- Acronym: GRAFFITI
- Condition: Coronary Artery Disease
- Intervention (Procedure): Surgical revascularization
- Lead sponsor: Onze Lieve Vrouw Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Onze Lieve Vrouw Hospital (`cardio:org-onze-lieve-vrouw-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial (`cardio:pubmed-31270037`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 57da612f2b53f5e5d07897730d2cc8a0c296e76915e3aeef005809c1c0cc8688
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
